M Røpke1, C Bulai Livideanu2, R Kaldate3, A Snel1, C Paul2. Show Affiliations » 1. LEO Pharma A/S, Ballerup, Denmark. 2. Paul Sabatier University and Larrey University Hospital, Toulouse, France. 3. Myriad Genetics, Salt Lake City, UT, U.S.A.
Abstract
Entities: Chemical Disease Gene
Mesh： See more » Adiponectin/metabolismAdministration, CutaneousAerosolsAnti-Inflammatory Agents/administration & dosageBetamethasone/administration & dosageBetamethasone/analogs & derivativesCalcitriol/administration & dosageCalcitriol/analogs & derivativesChemokine CCL22/metabolismDermatologic Agents/administration & dosageDrug Therapy, CombinationFemaleHumansInterleukin-17/metabolismMaleMiddle AgedPsoriasis/drug therapyTreatment Outcome
Substances： See more » AdiponectinAerosolsAnti-Inflammatory AgentsChemokine CCL22Dermatologic AgentsIL17A protein, humanInterleukin-17calcipotrienebetamethasone-17,21-dipropionateBetamethasoneCalcitriol
Year: 2017 PMID： 28722136 DOI： 10.1111/bjd.15814
Source DB: PubMed Journal: Br J Dermatol ISSN： 0007-0963 Impact factor: 9.302